Labcorp Partners with Roche to Expand Digital Pathology and Advance AI Integration in Diagnostics
Reuters
Sep 30
Labcorp Partners with Roche to Expand Digital Pathology and Advance AI Integration in Diagnostics
Labcorp Holdings Inc. has announced a collaboration with Roche to advance digital pathology capabilities across its diagnostics and biopharma laboratory services. Through this partnership, Labcorp will implement Roche's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners, enabling pathologists to diagnose patients using digital images and supporting future integration of artificial intelligence. The initiative is designed to improve diagnostic accuracy, streamline operations, and facilitate efficient data sharing and centralized review, particularly in the face of a projected shortage of pathologists in the U.S. This collaboration builds on Labcorp's ongoing relationship with Roche and aims to enhance patient care through innovative technology solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC86578) on September 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.